Mirae Asset Global Etfs Holdings Ltd. Arvinas, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Arvinas, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 26,032 shares of ARVN stock, worth $650,019. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,032Holding current value
$650,019% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARVN
# of Institutions
224Shares Held
68.7MCall Options Held
166KPut Options Held
31.3K-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$168 Million6.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.67MShares$167 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$156 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.99MShares$99.6 Million0.01% of portfolio
-
Avidity Partners Management LP Dallas, TX2.99MShares$74.6 Million3.91% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.33B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...